Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting

Atherosclerosis

Volumn 159, Issue 2, 2001, Pages 527-528

  Okumura, Kenji ^a,b   Kamiya, Hiroki ^a,b   Matsui, Hideo ^a,b   Sone, Takahito ^a,b   Kondo, Junichiro ^a,b   Tsuboi, Hideyuki ^a,b   Mukawa, Hiroaki ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

ALLELE; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY STENT; DNA POLYMORPHISM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME POLYMORPHISM; GENE AMPLIFICATION; GENE DELETION; GENOTYPE; HUMAN; INTRAVASCULAR ULTRASOUND; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTENOSIS;

ALLELES; ANGIOPLASTY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOQUINOLINES; MALE; PEPTIDYL-DIPEPTIDASE A; PROBABILITY; RECURRENCE; SENSITIVITY AND SPECIFICITY; STENTS; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME;

EID: 0035199206     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00720-1     Document Type: Letter

References (9)

1. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound
2. Effect of ACE inhibitors on angiographic restenosis sfter coronary stenting (PARIS): A randomized, double-blind, placebo-controlled trial
3. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy
4. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II
5. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting
6. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
7. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
8. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition
9. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy